Smarter Investment and value realisation

Australia spends $7.6 billion a year on health and medical research and innovation. We make the case for investing in strategically.

Our position: health and medical research and innovation needs strategic investment across the full pipeline, from discovery to implementation. That’s how we maximise its health, economic and social impact, and strengthen Australia’s global competitiveness. We produce evidence and bring the sector together to make that case.

CASE STUDY

What we did, and what happened next

A funding gap we identified saw the government commit to lifting MRFF disbursements to $1 billion a year from 2030-31.

The Case for Investing

Why research funding pays

returned to the Australian economy for every $1 invested in health and medical research.

1.69%→3%

Australia invests 1.69% of GDP in R&D. We’re calling for a measurable path to 3%.

78%

of Australians name increased health and medical research funding a key government spending priority.

The Proof

Evidence on this platform

Every item below is citable.

Report

Arthritis

2026

The MRFF & government funding

Disbursement analysis across five years of missions.

Report

Clinical trials

2025

Pre-budget submission 2026–27

Submitted by Research Australia on behalf of our members, January 2026.

Communique

Digital health

2025

Pre-budget submission 2025–26

Submitted by Research Australia on behalf of our members, January 2025.